Showing results (421-430 of 484) with videos related to

Sort By:
Pageof 49
JTO Clinical and Research Reports|December 3, 2024
Phase II Trial of Regorafenib and Oral Methotrexate in Previously Treated Advanced KRAS-Mutant NSCLCJacqueline V Aredo, Heather A Wakelee, Kavitha J Ramchandran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2022
Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non-Small-Cell Lung Cancer Previously Treated With Immunotherapy-Lung-MAP S1800AKaren L Reckamp, Mary W Redman, Konstantin H Dragnev, et al.
JTO Clinical and Research Reports|March 7, 2023
Osimertinib in NSCLC With Atypical EGFR-Activating Mutations: A Retrospective Multicenter StudyJingran Ji, Jacqueline V Aredo, Andrew Piper-Vallillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2018
SELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung CancerNathan A Pennell, Joel W Neal, Jamie E Chaft, et al.
JTO Clinical and Research Reports|May 31, 2022
High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A Multi-Institutional ExperienceA J Piper-Vallillo, Julia K Rotow, Jacqueline V Aredo, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2022
ANtiangiogenic Second-line Lung cancer Meta-Analysis on individual patient data in non-small cell lung cancer: ANSELMAJordi Remon, Benjamin Lacas, Roy Herbst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2025
First-Line Mobocertinib Versus Platinum-Based Chemotherapy in Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer in the Phase III EXCLAIM-2 TrialPasi A Jänne, Bin-Chao Wang, Byoung Chul Cho, et al.
Cancer Reports (Hoboken, N.J.)|August 28, 2025
Etirinotecan Pegol (NKTR-102) in Patients With Active Brain Metastases From Lung or Breast CancerSeema Nagpal, Kim-Son Nguyen, Sophie Bertrand, et al.
Medrxiv : the Preprint Server for Health Sciences|March 31, 2025
Napsin A-specific T cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancerNatalie J Miller, Christina S Baik, Joel W Neal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 24, 2017
Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancerMichael F Gensheimer, Julian C Hong, Christine Chang-Halpenny, et al.
Pageof 49